l-carnitine tmao nature medicine 2013 koeth
l-carnitine tmao nature medicine 2013 koeth γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of to Frontiers | The gut microbial
Frontiers The gut microbial metabolite trimethylamine N oxide and cardiovascular diseases Trimethylamine N Oxide and Related Gut Microbe Derived Metabolites and Incident Heart Failure Development in Community Based Populations Circulation: Heart Failure Gut Metabolite Trimethylamine N Oxide in Atherosclerosis: From Mechanism to Therapy Frontiers l carnitine tmao nature medicine 2013 koeth Non lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis: Cell Cardiovascular risk of dietary trimethylamine
USD23.27
USD73.27
Pay in 4 interest-free payments of $5.82 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
